Rocket Pharmaceuticals | Sustainability Performance
Conducts research and development of gene therapy treatments targeting rare genetic diseases. Activities involve clinical trials, regulatory interactions, and collaborations with scientific partners to develop therapeutic options addressing unmet medical needs.
1999
United States
201 - 500 employees
Biotechnology
$10M - 25M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#5805
Overallⓘ#1297
in United Statesⓘ#135
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
Powered by illuminem
